WHO ICTRP trial
Botulinum Toxin Type A Combining Triamcinolone and 5-Fluorouracil in the…
ChiCTR2100049402 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100049402 |
|---|---|
| Public title | Botulinum Toxin Type A Combining Triamcinolone and 5-Fluorouracil in the Treatment of Scars: A Prospective, Open Clinical, Randomized Controlled Trial |
| Scientific title | Botulinum Toxin Type A Combining Triamcinolone and 5-Fluorouracil in the Treatment of Scars: A Prospective, Open Clinical, Randomized Controlled Trial |
| Primary sponsor | Shanghai 9th Peoples Hospital Affiliated to Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | scar |
| Interventions | experimental group:Use botulinum toxin type A combining triamcinolone and 5-fluorouracil;control group:Use triamcinolone combining 5-flurouracil |
| Registration date | Aug 2, 2021 |
| Target size | experimental group:17;control group:17 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: